Stoke Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | +313.5% | -29.2% | +316.3% | +404.5% | |
| – | +89.4% | +110.3% | +328.0% | +15.8% | +58.5% | +33.8% | -6.1% | – | |
| – | – | – | – | – | – | -29.2% | +316.3% | +404.5% | |
| – | +132.7% | +183.9% | +35.5% | +68.2% | +43.7% | +5.6% | +8.4% | +54.7% | |
| – | +125.5% | +170.2% | +75.0% | +53.0% | +22.0% | +6.2% | +18.1% | +37.5% | |
| – | +130.1% | +179.1% | +48.7% | +62.3% | +35.7% | +5.8% | +11.6% | +48.6% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +2,501.7% | +217.4% | +27.6% | -99.9% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | -1,561.9% | – | – | – | – | -2,050.9% | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.